05/29/2026
There's a newer option for adults with treatment-resistant depression — and it starts with a simple nasal spray. Esketamine nasal spray, sold under the brand name SPRAVATO®, is an FDA-approved treatment used alongside an oral antidepressant to target depression at a neurological level.
At Psychiatric Care Center, our team supervises every session in a safe, welcoming environment. Treatment begins twice a week and gradually decreases over time — making it a structured, manageable addition to your care plan.
If traditional antidepressants haven't worked for you, esketamine nasal spray may be worth exploring with your provider.
👉 https://pcccares.com/spravato-redding/
📌 SPRAVATO® is a prescription medication available only through a certified healthcare provider. Individual results may vary. Please arrange transportation home following each session. Consult a qualified provider to see if SPRAVATO® is right for you.